<SEC-DOCUMENT>0001140361-21-006664-index.html : 20210301 <SEC-HEADER>0001140361-21-006664.hdr.sgml : 20210301 <ACCEPTANCE-DATETIME>20210301163552 ACCESSION NUMBER: 0001140361-21-006664 CONFORMED SUBMISSION TYPE: S-3ASR PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20210301 DATE AS OF CHANGE: 20210301 EFFECTIVENESS DATE: 20210301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3ASR SEC ACT: 1933 Act SEC FILE NUMBER: 333-253719 FILM NUMBER: 21698452 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 </SEC-HEADER> <DOCUMENT> <TYPE>S-3ASR <SEQUENCE>1 <FILENAME>nt10020928x1_s3asr.htm <DESCRIPTION>FORM S-3ASR <TEXT> Document 1 - file: nt10020928x1_s3asr.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>nt10020928x1_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: nt10020928x1_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>nt10020928x1_ex23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: nt10020928x1_ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-25.1 <SEQUENCE>4 <FILENAME>nt10020928x1_ex25-1.htm <DESCRIPTION>EXHIBIT 25.1 <TEXT> Document 4 - file: nt10020928x1_ex25-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>logo_biocryst2a.jpg <TEXT> Document 5 - file: logo_biocryst2a.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>nt10020928x1_ex25-1img01.jpg <TEXT> Document 6 - file: nt10020928x1_ex25-1img01.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>nt10020928x1_ex25-1img02.jpg <TEXT> Document 7 - file: nt10020928x1_ex25-1img02.jpg
</DOCUMENT> </SEC-DOCUMENT>